Clinical Trial Update: Study of Niraparib With Radiotherapy for Treatment of Metastatic Invasive Carcinoma of the Cervix [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 trial evaluating niraparib in combination with radiotherapy for metastatic cervical cancer was terminated; results were posted on 2024-06-18.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• Niraparib (Niraparib)

Snippet

Sponsor: Michelle S Ludwig | Conditions: Metastatic Carcinoma of the Cervix | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2024-06-18